PortfoliosLab logo

BioLineRx Ltd. (BLRX)

Equity · Currency in USD · Last updated Mar 27, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in BioLineRx Ltd. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $94 for a total return of roughly -99.06%. All prices are adjusted for splits and dividends.

BLRX (BioLineRx Ltd.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BLRX

BioLineRx Ltd.


BioLineRx Ltd. had a return of 33.90% year-to-date (YTD) and -50.00% in the last 12 months. Over the past 10 years, BioLineRx Ltd. had an annualized return of -29.39%, while the S&P 500 had an annualized return of 9.82%, indicating that BioLineRx Ltd. did not perform as well as the benchmark.

1 month31.67%-0.66%
6 months-15.96%5.67%
1 year-50.00%-10.89%
5 years (annualized)-44.09%8.95%
10 years (annualized)-29.39%9.82%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current BioLineRx Ltd. Sharpe ratio is -0.65. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

BLRX (BioLineRx Ltd.)
Benchmark (^GSPC)

Dividend History

BioLineRx Ltd. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

BLRX (BioLineRx Ltd.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the BioLineRx Ltd.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the BioLineRx Ltd. is 99.33%, recorded on Feb 24, 2023. The portfolio has not recovered from it yet.



To Bottom


To Recover



-99.33%Jul 26, 20112863Feb 24, 2023

Volatility Chart

Current BioLineRx Ltd. volatility is 78.51%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

BLRX (BioLineRx Ltd.)
Benchmark (^GSPC)